Advertisement
UK markets close in 7 hours 28 minutes
  • FTSE 100

    8,123.07
    +44.21 (+0.55%)
     
  • FTSE 250

    19,746.47
    +144.49 (+0.74%)
     
  • AIM

    755.84
    +2.72 (+0.36%)
     
  • GBP/EUR

    1.1649
    -0.0008 (-0.07%)
     
  • GBP/USD

    1.2514
    +0.0003 (+0.03%)
     
  • Bitcoin GBP

    51,417.89
    +236.97 (+0.46%)
     
  • CMC Crypto 200

    1,388.37
    -8.17 (-0.58%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.00
    +0.43 (+0.51%)
     
  • GOLD FUTURES

    2,358.20
    +15.70 (+0.67%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,661.35
    +376.81 (+2.18%)
     
  • DAX

    18,026.85
    +109.57 (+0.61%)
     
  • CAC 40

    8,041.66
    +25.01 (+0.31%)
     

Company News For Sep 4, 2019

  • Conn's, Inc.’s CONN shares rose 18.3% after the company reported second quarter fiscal 2020 earnings per share of $0.62, surpassing the Zacks Consensus Estimate of $0.51

  • The Medicines Company’s MDCO shares gained 10.4% after the company reported positive results from its ORION-11 trial at ESC Congress 2019.

  • Shares of Emergent BioSolutions Inc. EBS surged 14.5% after the company received a 10-year HHS contract to provide ACAM2000 smallpox vaccines to the U.S. Strategic National Stockpile

  • Shares of Royal Caribbean Cruises Ltd. RCL fell 1.4% afterthe reorts surfaced that the company could suffer losses of up to $0.05 a share in the current quarter due to the impact of Hurricane Dorian


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report
 
Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report
 
The Medicines Company (MDCO) : Free Stock Analysis Report
 
Conn's, Inc. (CONN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research